Kayla Townsley
About Me
As a post-bacc, Kayla Townsley conducted research in the lab of Dr. Angela Ozburn at Oregon Health and Science University studying the molecular mechanisms underlying addiction and conducted pharmaceutical screenings of novel therapeutics for alcohol use disorders. Currently her research interests include the relationship between epigenetic modifications, brain plasticity, and affective disorders, and the intersection of these areas that can contribute to the comorbidity of substance use disorders and psychiatric disorders. She also finds the interactions between the epigenetic influences that contribute to an addiction phenotype and an individual's genetics that may confer susceptibility or resistance to that phenotype an intriguing area for exploration — one that has implications for both our understanding of basic epigenetic mechanisms as well as having clinical relevance for improved treatment options.
Language
English
Research Topics
Addiction, Brain, Epigenetics, Genetics, Neuroscience, Psychiatry
Multi-Disciplinary Training Areas
Neuroscience [NEU]
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. TOWNSLEY has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.